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The nematode worm Caenorhabditis elegans has emerged as an important model organism to study the 28 
molecular mechanisms of protein misfolding diseases associated with amyloid formation because of its 29 
small size, ease of genetic manipulation and optical transparency. Obtaining a reliable and quantitative 30 
read-out of protein aggregation in this system, however, remains a challenge. To address this problem, 31 
we here present a fast time-gated fluorescence lifetime imaging (TG-FLIM) method and show that it 32 
provides functional insights into the process of protein aggregation in living animals by enabling the 33 
rapid characterisation of different types of aggregates. More specifically, in longitudinal studies of C. 34 
elegans models of Parkinson’s and Huntington’s diseases, we observed marked differences in the 35 
aggregation kinetics and the nature of the protein inclusions formed by α-synuclein and polyglutamine. 36 
In particular, we found that α-synuclein inclusions do not display amyloid-like features until late in the 37 
life of the worms, whereas polyglutamine forms amyloid characteristics rapidly in early adulthood. 38 
Furthermore, we show that the TG-FLIM method is capable of imaging live and non-anaesthetised 39 
worms moving in specially designed agarose micro-chambers. Taken together, our results show that the 40 
TG-FLIM method enables high-throughput functional imaging of living C. elegans that can be used to 41 
study in vivo mechanisms of aggregation and that has the potential to aid the search for therapeutic 42 
modifiers of protein aggregation and toxicity.  43 
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A variety of human diseases, including neurodegenerative disorders such as Parkinson’s and 44 
Alzheimer’s diseases, are characterised by the misfolding of protein species and their subsequent 45 
aggregation into amyloid fibrils1,2. The nematode Caenorhabditis elegans is a particularly useful model 46 
organism through which to study these diseases3–8 and to screen for small molecule inhibitors of the 47 
protein aggregation process9,10. C. elegans has a simple body plan of 959 somatic cells, its genetics are 48 
well-characterised, and at least 40% of its genes have known human homologs11. Furthermore, it has a 49 
relatively short lifespan of only 2-3 weeks and is optically transparent, making it a highly suitable 50 
system for longitudinal imaging studies of protein aggregation. Despite these advantages, obtaining 51 
quantitative read-outs for amyloidogenic protein aggregation in vivo remains challenging12. 52 
Fluorescence intensity measurements are prone to artefacts, and classifying aggregates by counting 53 
protein inclusions relies on arbitrary choices for intensity and size cut-offs. Furthermore, reliable 54 
discrimination between amyloid-like and amorphous aggregates is generally not possible. The use of 55 
thioflavin T, a dye that becomes fluorescent on intercalation into the cross b-structure of amyloid 56 
aggregates, and that is commonly used for the study of protein aggregation in vitro, is not compatible 57 
with live worm imaging because it affects protein homeostasis in the nematodes13.  58 
To address some of these issues, we have previously established a readout for the state of protein 59 
aggregation based on fluorescence lifetime imaging microscopy (FLIM) of a fluorophore covalently 60 
linked to the amyloidogenic protein of interest14. FLIM not only informs on the location but also on the 61 
molecular environment of the fluorescent probes, providing fully quantitative read-outs15–17. We have 62 
shown that a reduction in lifetime from the reporter fluorophore correlates with the degree of 63 
aggregation of the protein to which it is attached, and that this provides a quantitative measure of the 64 
degree of protein aggregation in vitro, in live cells and in C. elegans14. The decrease in lifetime is 65 
thought to be associated with fluorescence energy transfer to intrinsic energy states associated with the 66 
amyloid fibrils14. Conjugated organic fluorophores18–20 and intrinsic protein fluorescence21 have also 67 
been used successfully as FLIM sensors for protein aggregation, as has the amyloid-binding dye 68 
heptamer-formyl thiophene acetic acid (hFTAA)22. Conventional FLIM measurements are slow, 69 
however, as they are based on time-correlated single photon counting (TCSPC)23,24 which involves 70 
acquisition times on the order of 2 min for a single field of view. This method therefore requires the use 71 
of anaesthetised or fixed animals, greatly limiting the throughput of the technique and preventing 72 
studies of freely moving, live animals. 73 
In this work, we specifically set out to address these problems and to establish a method that improves 74 
throughput and physiological relevance and permits studies of moving animals. The method makes use 75 
of time-gated FLIM (TG-FLIM)25, a fast and quantitative imaging modality which provides 76 
unprecedented throughput for FLIM measurements of non-paralysed animals. Unlike TCSPC, which is 77 
usually performed in conjunction with laser scanning confocal microscopy (LSCM), TG-FLIM is a 78 
wide-field technique and thus heavily parallelises the FLIM measurements. The fluorescence decay is 79 
4 
 
measured by collecting the fluorescence signal with nanosecond-wide temporal gates, which are 80 
temporally shifted to enable the fluorescence decay to be sampled. Gating and time shifting are achieved 81 
with a high-rate imager (HRI), and lifetime data are thus obtained in each pixel from a sequential set of 82 
images gated at different time delays (Figure 1a, see Supporting Information). TG-FLIM has been 83 
successfully used for high-throughput imaging of protein-protein interactions and biosensors in 84 
cells26,27, but not so far in the context of protein aggregation, or in worm models of disease. Here, we 85 
describe a novel approach for aggregation studies in C. elegans models of protein misfolding diseases 86 
based on TG-FLIM. We show that we can monitor intracellular aggregation in the worms over their 87 
entire lifespan using TG-FLIM with excellent repeatability and precision in the measured lifetimes. Our 88 
approach reveals differences in the kinetics of protein aggregation and the type of species appearing in 89 
the worms for two disease models. Furthermore, we provide details of the quantification of TG-FLIM 90 
data from live, moving animals and introduce motion correction algorithms for the TG-FLIM data 91 
analysis. 92 
 93 
Results and discussion 94 
Time-gated FLIM provides a robust lifetime readout from C. elegans 95 
A schematic of the TG-FLIM microscope setup that we have developed is shown in Figure 1a, details 96 
of which are found in the Methods section and in Supplementary Figure 1. To assess the precision 97 
and repeatability of the method, we measured the fluorescence lifetimes of yellow fluorescent protein 98 
(YFP) when expressed in C. elegans. Figure 1c shows the head region of worms expressing YFP in 99 
body wall muscle cells. For the purpose of these experiments, the worms were anaesthetised. The 100 
average standard deviation across pixels within a single field of view was 17 ps (as shown by the error 101 
bars on Figure 1d). The variability between individual worms was estimated by comparing the mean 102 
lifetimes obtained from the worms and found to be 16 ps (standard deviation). The system exhibited 103 
excellent intra-frame and inter-frame repeatability of the value of the fluorescence lifetimes measured 104 
in this way. The results presented in Figure 1c,d were obtained by acquiring 61 equally-spaced gates 105 
with exposure times of 65 ms each. The gate width was set to 1 ns and the time gated images were 106 
acquired every 250 ps, leading to a total acquisition time of 4.2 s per field of view. This corresponds to 107 
a ~30-fold improvement in speed compared to typical TCSPC measurements of similar quality14, thus 108 
allowing for a much higher throughput. The results, therefore, show that TG-FLIM is a robust and 109 
quantitative readout for biosensors in C. elegans, featuring good spatial and temporal resolution 110 




Figure 1. TG-FLIM imaging of live C. elegans expressing YFP in the body wall muscle cells. (a) 113 
Schematic of the FLIM setup, showing the excitation pulse (blue curve), the fluorescence emission 114 
decay (green curve) and the gated detection (red curve) performed by the high-rate imager (HRI). The 115 
fluorescence lifetime (𝜏) is measured by gating the fluorescence decay with a gate width (𝑤) and a set 116 
of gate positions (∆𝑡). (b) Bright-field image acquired with the HRI camera (top), schematic FLIM 117 
stack consisting of images recorded at different time gates (middle), and the reconstructed fluorescence 118 
lifetime map obtained through such measurements from a single worm head region (bottom). (c) 119 
Fluorescence lifetime maps of 20 individual worms. Each field of view represents a 225 µm x 167 µm 120 
region in the sample plane. (d) Average lifetimes obtained from individual worms demonstrating the 121 
precision (error bars are standard deviation across pixels within the field of view) and the variability of 122 
lifetimes between individual worms in one experiment. 123 
Longitudinal FLIM studies of Parkinson’s and Huntington’s disease models 124 
We then explored if the method is capable of detecting age-associated protein aggregation in C. elegans 125 
models of protein misfolding diseases. To this end, we carried out a longitudinal study of the 126 
fluorescence lifetimes and the distribution of the aggregates that form in C. elegans models for 127 
Parkinson’s disease and for polyglutamine expansion disorders such as Huntington’s disease, 128 
expressing YFP-tagged α-syn5 and polyglutamine (40 glutamine residues, Q40)4, respectively, in the 129 
body wall muscle cells. We focused on imaging the head region of the worms and obtained sufficient 130 
resolution to be able to identify individual inclusions. Data were recorded across the whole lifespan of 131 
a population of nematodes, using the strain expressing only YFP as a control. We imaged a pool of ca. 132 
20 worms for each strain (ca. 60 worms in total) on days 0, 3, 6, 10, 12 and 14 of adulthood for two 133 
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independent biological replicates. The fluorescence lifetimes for each population and representative 134 
TG-FLIM images are shown in Figure 2. 135 
 136 
Figure 2. TG-FLIM imaging of protein aggregation in Q40 and α-syn strains across the lifespan of the 137 
animals. (a) Fluorescence lifetimes at day 0, 3, 6, 10, 12, and 14 of adulthood for Q40 and α-syn 138 
compared to YFP controls. Squares and circles represent the average lifetime of the fluorescence from 139 
the head region of each imaged worm. Statistical analysis was performed using a one-way ANOVA, 140 
*** p<0.005, **** p<0.0001. The data shown are pooled from two biological replicates totalling ca. 40 141 
worms per strain and time point. An F-test of YFP control lifetimes comparing data over the 15 days 142 
showed no significant deviation from a zero-slope, indicating that our data are compatible with a 143 
constant lifetime for the YFP control over the lifespan of the animal (p=0.90). (b) Representative worm 144 
FLIM images for each day and each strain. 145 
 146 
While the YFP control remained constant over the lifespan of the animal (as examined by an F-test), 147 
we observed that the average fluorescence lifetime of Q40 dropped early in the life of the worms 148 
(between day 0 and day 3) and remained constant throughout the rest of their lifespan (Figure 2a). At 149 
day 0, the Q40 worms presented a combination of bright inclusions with lower fluorescence lifetimes 150 
than the YFP control, indicative of protein molecules being in an amyloid state14, as well as diffuse 151 
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signal with lifetimes similar to that of the YFP control, therefore indicative of a non-amyloid state 152 
(Figure 2b and Figure 3a,c). The fluorescence lifetime distribution of Q40 at day 0 exhibits two peaks, 153 
in agreement with the presence of the soluble and aggregated forms. The diffuse signal was not observed 154 
from day 3 onwards, and we infer that at this stage of the worm life all soluble protein had been 155 
incorporated in amyloid-like inclusions in agreement with the significantly lower average lifetimes of 156 
ca. 2850 ps compared to the YFP control of ca. 2950 ps (Figure 2a). These results are consistent with 157 
previous fluorescence recovery after photobleaching (FRAP) studies, where the diffuse Q40 observed 158 
in young animals was found to be relatively mobile, compared to the Q40 inclusions which were 159 
immobile4,28. In addition, these data are in agreement with the propensity of polyQ stretches in isolation, 160 
as well as in the context of huntingtin exon 1, to form fibrils in vitro29 and in vivo 30–32. 161 
In contrast to the Q40 animals, the fluorescence lifetime of α-syn remained similar to that of the YFP 162 
control worms until day 10, after which a reduction in lifetime was observed (Figure 2a). Detailed 163 
analysis revealed that inclusions were present in α-syn worms from day 0 onwards, yet these did not 164 
correspond to highly ordered aggregates as judged from the uniform fluorescence lifetimes observed 165 
across the animals throughout most of their lifespan (Figure 2b and Figure 3b,d). Only late in the life 166 
of the animal, after day 10, did we observe α-syn inclusions with fluorescence lifetimes indicative of 167 
well-defined amyloid fibrils (Figure 2b). Analysis of the expression levels by Western blot revealed 168 
that the α-syn concentration decreased during ageing (Supplementary Figure 2), which does not affect 169 
the lifetime values but may only lead to a small reduction in the precision of the measurement. Again, 170 
the FLIM results are consistent with FRAP data, in which immobile inclusions were observed only from 171 
day 11 onwards5.  172 
As an independent confirmation of the differences between the inclusions formed by Q40 and α-syn, 173 
we lysed the worms in detergent-containing buffer at day 6 of adulthood, and observed that α-syn was 174 
fully dispersed and localised to the soluble fractions, whereas Q40 inclusions persisted and were present 175 
in the pellet fractions (Supplementary Figure 3). 176 
The precise molecular nature of the earlier α-syn inclusions is unclear at present, but we speculate that 177 
they could either be disordered oligomeric species as observed in the early stages of α-syn aggregation 178 
in previous studies33,34, accumulations of monomeric α-syn with lipids or other cellular components, or 179 
perhaps droplets with liquid-like properties which have recently attracted attention as possible 180 




Figure 3. Representative protein aggregation of Q40 (a,c) and a-syn (b,d) at day 0 and day 6 revealed 183 
by TG-FLIM images. (a) Representative images of Q40 worms at day 0 (top) and day 6 (bottom). 184 
Shown are the false-colour FLIM maps (left), the signal intensity (middle) and the intensity-merged 185 
FLIM maps (right). The FLIM and intensity maps show that the protein is distributed between diffuse 186 
signal and foci, the latter having a shorter lifetime. (b) Representative images of a-syn worms at day 0 187 
(top) and day 6 (bottom), presenting bright inclusions with comparable fluorescence lifetime as the 188 
diffuse signal. (c) Fluorescence lifetime histogram of Q40 protein, obtained from the animal shown in 189 
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(a) at day 0 and day 6. d) Fluorescence lifetime histogram of a-syn protein, obtained from the animal 190 
shown in (b). 191 
 192 
Thus, this longitudinal TG-FLIM study reveals clear differences in the kinetics of the aggregation 193 
process for strains expressing Q40 and α-syn, and informs on the nature of the protein inclusions in vivo 194 
as the animals age.  195 
 196 
TG-FLIM imaging of live C. elegans crawling in agarose micro-chambers 197 
Imaging studies of C. elegans are typically performed on anaesthetised animals in order to circumvent 198 
motion artefacts at the examined length- and time-scales. Although the animals remain alive during the 199 
experiment, the use of anaesthetics is not compatible with the observation of behavior, nor does it allow 200 
an individual animal to be monitored over long periods of time. Given the exceptional speed and 201 
precision of TG-FLIM, we set out to examine its applicability for imaging live and crawling C. elegans. 202 
To this end, we designed agarose micro-chambers that can hold individual worms (Figure 4a), inspired 203 
by previous studies on both C. elegans larvae and adults36,37. The dimensions of the micro-chambers 204 
were chosen so that worms remained within the field of view and the depth of field of the microscope 205 
and were able to crawl freely within the micro-chamber as shown in the supplementary video (see 206 
Supplementary Figure 4).  207 
As a benchmark for this approach, we inserted C. elegans expressing YFP and Q40 at day 3 of adulthood 208 
in the micro-chambers for TG-FLIM measurements (Figure 4). To increase acquisition speed, we used 209 
only 7 time gates (gate width of 1 ns with time gates acquired every 2.175 ns) compared to the 61 used 210 
for studies described in the preceding sections, thus shortening the total recording time to just 0.5 s per 211 
FLIM acquisition and minimising movement artefacts across the TG-FLIM dataset, while enabling 212 
sufficient data quality.  213 
Although the worms did not move on the timescale of the individually recorded frames in our TG-FLIM 214 
measurements, motion over the entire acquisition sequence (0.5 s) caused significant artefacts during 215 
the FLIM reconstruction, as a consequence of the loss of spatial correspondence of image pixels 216 
between the different time gates (Supplementary Figure 5). In order to correct for the worm movement 217 
during the data acquisition, we developed an image registration procedure that re-aligns each dataset 218 
before FLIM analysis, similar to that used previously to remove motion artefacts from intravital 219 
imaging38. The procedure uses a non-rigid transformation to register features in each individual frame 220 
compared to the brightest frame of the given TG-FLIM dataset. We quantified the resulting standard 221 
deviations on control worms and found a lower fluorescence lifetime resolution compared to the 222 
experiments on anaesthetised animals (higher standard deviation of ca. 60 ps with 7 gates, compared to 223 
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17 ps with 61 gates, with a similar level of signal in the maximum time gate). This difference can be 224 
explained by a lower sampling rate of the fluorescence decay and therefore a lower number of total 225 
photons in the decay, as well as residual errors in registration adding some noise to the fluorescence 226 
lifetime estimation. 227 
Additionally, we implemented a digital “worm stretching” procedure inspired by the work of 228 
Christensen et al.39. This approach has two major advantages: first, it allows for the averaging of 229 
fluorescence lifetime maps of the same worm if consecutively imaged, improving the signal-to-noise 230 
ratio (SNR) of the resulting lifetime map. Second, it allows alignment of images of multiple worms 231 
along a similar template (a “stretched” form of the worm), which enables a direct comparison of 232 
multiple datasets for the assessment of the distribution of markers and functional read-outs. Being able 233 
to visualise data in a tractable way is important especially when a high throughput approach is taken. 234 
The digital stretching was performed by first determining the worm outline and drawing the backbone 235 
of the worm via skeletonisation, using a similar approach to that used for tracking worms40. The 236 
backbone was then used to extract the information about the curvature of the worm, which in turn 237 
allowed reconstruction of the signal from the digitally stretched worm (see Methods for details). 238 
Representative results of the YFP control and Q40 worms are shown in Figure 4b. The fluorescence 239 
lifetime maps of the worms were digitally stretched as described above and 10 consecutive fluorescence 240 
lifetime maps were averaged in order to achieve a comparable image quality to that obtained in our 241 
study on the anaesthetised worms. The fluorescence lifetime maps reconstructed here show no visible 242 
artefacts despite the motion of the worms during the acquisition. Additionally, we found that the 243 
fluorescence lifetimes obtained this way are in good agreement with those obtained in the experiments 244 
on immobilised animals (compare Figure 4b to Figure 2b). These measurements therefore permit 245 
functional imaging of aggregate states in entire worms, and enable their behavior to be monitored over 246 
time. Furthermore, the visualisation of worms as stretched templates, as in Figure 4b, allows a direct 247 
comparison of the degree of aggregation (derived from the FLIM measurement) and of the spatial 248 




Figure 4. TG-FLIM applied to live C. elegans crawling in agarose micro-chambers. (a) Schematic of 251 
the agarose-based micro-chamber device loaded with C. elegans (top) and an image of four chambers, 252 
each occupied by a single worm (bottom). (b) Registered and digitally stretched fluorescence lifetime 253 
maps of live crawling C. elegans. Shown here are example images of YFP and Q40 worms at day 3 of 254 
adulthood. For each worm, 10 sequential FLIM acquisitions were carried out (equalling a total 255 
acquisition time of ~5 s, therefore comparable to that used for anaesthetised worms ~4.2 s), and the 256 
fluorescence lifetime maps were averaged after digital stretching.  257 
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Concluding remarks 258 
In conclusion, we have presented here a method for the functional study of protein aggregation in live 259 
C. elegans. The method reveals differences in the aggregation kinetics and the nature of the inclusions 260 
formed during aging in models of Parkinson’s (a-syn) and polyglutamine expansion (Q40) diseases. 261 
We observed that a-syn became localised to inclusions prior to the decrease in fluorescence lifetime 262 
that is associated with amyloid formation, suggesting that the mechanism of a-syn aggregation involves 263 
the persistence of relatively disordered intermediate species prior to the formation of amyloid structure. 264 
We furthermore noticed a considerable spread in the fluorescence lifetimes of aged a-syn worms, 265 
suggesting that some animals remain largely unaffected by amyloid aggregation even at old age. By 266 
contrast, the data showed that Q40 accumulates completely into amyloid inclusions early in adulthood 267 
of the worm population. This approach could be extended to image young Q40 nematodes in larval 268 
stages at higher resolution, to find out if similar non-amyloid inclusions comprised of e.g. oligomeric28 269 
or liquid-like states41 are visible as precursors in this system.  270 
For the longitudinal studies described here, we were able to perform the complete set of experiments in 271 
less than 2.5 h for each day of measurement (ca. 20 worms for each of the 3 strains studied here). This 272 
fast acquisition time provides a high level of reproducibility and has major advantages for high-273 
throughput studies, as it limits the variability in worm age across the experiment while providing 274 
sufficient data to define the lifetime changes precisely. This feature constitutes a significant 275 
improvement compared to TCSPC where the measurement of ~60 worms would take over ~10 h on a 276 
single imaging day. The method also has much higher throughput than FRAP, providing information 277 
about the distribution and the aggregation states of all of the inclusions in the imaged region of the 278 
animal in one single acquisition. Crucially, TG-FLIM allows us to confirm the amyloid-like nature of 279 
the inclusions based on the ability of the FLIM sensor to distinguish between different forms of 280 
aggregation14, whereas FRAP informs solely on diffusion, which may be similarly restricted for 281 
multiple forms of aggregates. Given its speed, we anticipate that the TG-FLIM method will provide 282 
new avenues for high-throughput studies of in vivo protein aggregation, e.g. to screen for small 283 
molecules with the ability to inhibit this process42. 284 
We have in addition demonstrated two novel analytical approaches in combination with fast TG-FLIM 285 
to image moving nematode worms. The first one uses non-rigid transformation for gate realignment 286 
and correction of motional artefacts within the TG-FLIM dataset, which we note would not be possible 287 
with TCSPC measurements. The second uses a pseudo-templating method to allow for FLIM map 288 
averaging, and for the alignment of all the imaged worms from a given population for easy evaluation 289 
of variability and phenotypical properties, e.g. the size of the worms and the spatial distributions of the 290 
fluorescent marker. 291 
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The results set the stage to apply the fast TG-FLIM approach to more advanced types of chamber 292 
devices that could support long-term culturing of C. elegans, and enable protein aggregation in the same 293 
individual worm to be tracked over time. Agarose micro-chambers have been used to follow the 294 
development of C. elegans larvae43, but microfluidic devices may be necessary for long-term growth, 295 
providing a continuous supply of nutrients and separation of offspring as described e.g. by Cornaglia et 296 
al.44. The combination of our fast TG-FLIM approach with microfluidic or micro-chamber devices, 297 
such as the one that we have presented here, with fully automated data acquisition will greatly improve 298 
the throughput of the method compared to manual scanning, as used in the current study. This approach 299 
would constitute an invaluable tool for performing very large functional screens for genetic modifiers 300 
or compounds that perturb protein aggregation. Optical sectioning capabilities45 can also be added to 301 
the imaging procedure in order to reveal the 3D organisation of the system, which will provide important 302 
additional information e.g. on the subcellular localisation of protein inclusions. 303 
Finally, the fast FLIM imaging demonstrated here can reach a speed of 2 FLIM frames per second (as 304 
demonstrated by the 7 gates imaging experiments), and hence can lead to the observation of biologically 305 
relevant protein-protein interactions and biosensor dynamics in freely moving worms. Therefore, the 306 
use of this fast FLIM method opens up important avenues for time-dependent functional studies using 307 
other biosensors, for example to probe Ca2+ levels for monitoring neuronal activation while having 308 





TG-FLIM imaging. The TG-FLIM system was set up on an Olympus IX83 frame. The laser source 312 
was a super-continuum laser source Fianium SC400-4, spectrally selected by a combination of two 313 
linear variable filters and set up for epifluorescence excitation by focussing the beam in the back focal 314 
plane of the microscope objective. The fluorescence image was relayed onto the photocathode of a high-315 
rate imager (HRI, Kentech) and its phosphor screen was re-imaged onto the camera sensor (PCO 316 
pixelfly, USB, PCO). The magnification of the relays was set up such that the element size of the HRI 317 
matched the resolution of the microscope and that of the camera pixel size in 2x2 binning mode. Details 318 
of the architecture of the microscope are shown in Supplementary Figure 1. Imaging of worm heads 319 
was performed using a 40X objective (Olympus UApoN340 40X NA 1.35) and that of entire worms in 320 
imaging chambers was performed using a 10X (Olympus PlanFLN 10X NA 0.3) objective. The 321 
excitation wavelength was selected to be 516 nm (10 nm bandwidth) and the fluorescence was detected 322 
using a 550/49 (Semrock) filter. The instrument response function (IRF) was measured by taking an 323 
acquisition of a 1 mM solution of Erythrosin B (Sigma-Aldrich) solution in water. Additionally, the 324 
microscope was equipped with a CMOS camera (Blackfly S, BFS-U3-51S5M-C, FLIR) for bright-field 325 
measurement.  326 
FLIM lifetime image reconstruction. FLIM reconstruction was performed using the FLIMfit46 327 
package (v4.12.1) from the Open Microscopy Environment (OME). Data analysis was performed by 328 
subtracting a background image acquired separately and spatially-varying the IRF reference 329 
reconvolution using a lifetime of ~90 ps. A single exponential decay was fitted to the data on a single-330 
pixel basis.  331 
C. elegans culturing and sample preparation. Nematodes were grown under standard conditions on 332 
nematode growth media (NGM) plates seeded with Escherichia coli OP50 at 20 °C. Worm strains used 333 
in these experiments were AM134 expressing YFP, AM141 expressing glutamine40-YFP (Q40)4, and 334 
OW40 expressing human wild-type α-synuclein-YFP (α-syn)5, all under control of the unc-54 promoter 335 
to drive expression in body wall muscle cells. Age-synchronized worm populations were generated by 336 
a 4 h synchronized egg lay, and animals were transferred to NGM plates containing 75 µM 5-fluoro-337 
2’-deoxyuridine (FUDR, Sigma) at the fourth larval stage to inhibit the generation of offspring.  338 
For imaging, worms were transferred to a drop of M9 buffer (3 g L-1 KH2PO4, 6 g L-1 Na2HPO4, 0.5 gL-339 
1 NaCl, 1mM MgSO4) containing NaN3 as an anaesthetic on a freshly prepared pad of 2.5 % agarose. 340 
A cover slip was delicately placed on top and the sample was inverted for imaging on the inverted 341 
microscope. 342 
Preparation of C. elegans lysates and Western blot. At day 6 of adulthood, 6,000-9,000 animals were 343 
harvested for each of the strains YFP, Q40 and α-syn by washing them off NGM plates with M9 buffer. 344 
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Worm pellets were resuspended in RIPA buffer (Sigma) supplemented with protease inhibitor cocktail 345 
(Roche) and lysed using a cell homogeniser (Isobiotec). Lysates were fractionated by centrifugation in 346 
an Eppendorf microcentrifuge at 3,000 rpm (845 g) followed by 15,000 rpm (21,130 g). The fractions 347 
were inspected for fluorescence using a Leica MZ10 F stereomicroscope. 348 
Western blots were probed for YFP with antibody ab6556 (Abcam) and for tubulin with T6047 (Sigma) 349 
both diluted 1:5000. To examine protein expression levels during ageing, animals were picked directly 350 
into SDS/urea buffer (8 M urea, 2% SDS, 50 mM DTT, 50 mM Tris pH 8.0) and amounts corresponding 351 
to the same number of worms were loaded onto the gel for each of the time points (ca. 13 worms for 352 
YFP and ca. 37 worms for α-syn). For Q40 we observed that the protein inclusions largely failed to 353 
enter the gel even under denaturing conditions, and thus we were not able to quantify the expression 354 
levels for this strain. 355 
Imaging chambers. A silicon master with the desired microstructures was fabricated with standard 356 
photolithography techniques. The device was designed as an array of 19 x 16 micro-chambers spaced 357 
by 350 µm in both directions. The chambers were shaped as rounded rectangles (700 µm x 500 µm x 358 
80 µm depth) to fit within the field of view of the microscope when using the 10X objective (898 µm x 359 
671 µm). Micro-chamber devices were made by pouring 5% high-melting agarose in S-basal buffer 360 
(5.85 g L-1 NaCl, 1 g L-1 K2HPO4, 6 g L-1 KH2PO4, 5 mg L-1 cholesterol) onto the master in a petri dish, 361 
and carefully cutting it out after solidification. To allow for sufficient oxygen supply during prolonged 362 
imaging times, slits were cut on the back of the device.  A drop of E. coli OP50 resuspended in Luria 363 
Broth medium (10 g L-1 bacto-tryptone, 5 g L-1 bacto-yeast, 5 g L-1 NaCl) was applied onto the device, 364 
after which it was left to dry. Worms were washed off NGM plates with M9 buffer (3 g L-1 KH2PO4, 6 365 
g L-1 Na2HPO4, 0.5 g L-1 NaCl, 1mM MgSO4) and allowed to sediment, after which a ~100 µL drop of 366 
solution containing the worms was put onto the device. We observed that the worms tended to swim 367 
towards the bottom of the chambers as the drop was drying. However, spreading them with a platinum 368 
wire ensured a more homogeneous distribution with most chambers containing a single worm, or being 369 
empty. In our hands, the optimum chamber filling was achieved by loading ca. 150-200 worms onto the 370 
device, which contains 304 micro-chambers. As soon as the device was dry, a coverslip was put on top 371 
and a glass slide at the bottom, after which the sample was imaged in an inverted fashion. 372 
Correction of motion artefacts and digital stretching. The correction of motion artefacts was 373 
performed by using a non-rigid transformation using the MATLAB B-spline image registration written 374 
by Dirk-Jan Kroon (MathWorks File Exchange) and initially implemented by Rueckert et al.47. The 375 
brightest image of the fluorescence decay was used as a template. Each gate was re-scaled by histogram 376 
equalization prior to registration. The transformation obtained for each re-scaled gate was then applied 377 
to the corresponding original data. The registered dataset was then saved as OME-tiff for subsequent 378 
FLIM analysis. 379 
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The digital stretching was performed as followed: each total intensity image was re-scaled by histogram 380 
equalization followed by binarization (Otsu thresholding) and active contouring in order to obtain a 381 
faithful outline of the worm. The backbone of the worm was obtained by skeletonization and then used 382 
to calculate the position of the center of the worm along the geodesic line of the backbone. The backbone 383 
was subsequently smoothed by undersampled cubic spline interpolation. The coordinates along the 384 
geodesic line were used to estimate the angle of the worm at every point along the backbone and to 385 
rotate the image of the worm. For each position the section of the worm image normal to the backbone 386 
was obtained and the sections were used to reconstitute the stretched image of the worm. The 387 
transformation obtained this way could then be applied to the fluorescence lifetime image and total 388 
intensity map.  389 
Statistical analysis. All statistical analysis (one-way ANOVA and F-test for comparing with a zero-390 
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